RBOT
Vicarious Surgical Inc.
NYSE · Healthcare · Medical - Devices · US
$0.03
+3.67%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.03
From 52W high−99.56%
Volume125816.00
Market cap$184680.57
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$0.03
From 52W high
−99.56%
Volume
125816.00
Market cap
$184680.57
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
P/E (TTM)
—
RSI (14)
36.0
MomentumView details →
1D Return
+3.67%
YTD Return
−98.42%
SummaryUpdated Mar 1, 2026
Vicarious Surgical Inc. (NYSE:RBOT) is a medical device company founded in 2014 and headquartered in Waltham, Massachusetts. The company went public through a SPAC merger in September 2020. Vicarious Surgical is developing revolutionary single-incision surgical robotics technology that aims to transform minimally invasive surgery by virtually transporting surgeons inside the patient's body. The company is currently in the pre-commercial stage, having completed development of its Version 1.0 surgical system and preparing for its first clinical trials in 2025.
Similar companies
Latest newsMore news →
Vicarious Surgical shareholders voted to shut down and liquidate the company immediately.61d agoVicarious Surgical's board of directors proposes to dissolve and liquidate the company, seeking shareholder approval at a special meeting on July 21, 2026.67d agoSarah Romano resigned as Chief Financial Officer of Vicarious Surgical Inc., effective July 22, 2026.89d ago